iMediSync: 90%+ early detection accuracy of Alzheimer’s @ CES 2022

iMediSync mental health toolIf you’ve ever been around someone with a mental disorder, such as Alzheimer’s or other forms of dementia, you know it can be hard for everyone involved. Watching a loved one disappear into a fog of confusion and often anger is emotionally distressing for the caretakers and family. Unfortunately, there has not been any way to detect these issues early on with efficiency, making it difficult to treat before the disease progresses beyond repair. However, iMediSync has a new product to do just that.

Who is iMediSync?

iMediSync has developed a ground-breaking early detection and therapeutic platform for optimal brain health. Their first solution is its proprietary EEG database, which can detect Mild Cognitive Impairment (early stage of Alzheimer’s disease) with 90%+ accuracy. Clinical trials with multicenter hospitals have confirmed this accuracy. The vision of the company is to develop early-detecting biomarkers for challenging neurological disorders and diseases such as ADHD, depression, Parkinson’s, coma, and more.

Why is this important?

This is a huge step forward for the early detection of Alzheimer’s and other mental disorders. iMediSync has the potential to help millions of people who are currently undiagnosed and untreated. The earlier these issues can be detected, the better the chances are for a successful treatment outcome.

iMediSync is also working on developing new technologies to treat these diseases and disorders with EEG neuromodulation.

How does iMediSync work?

The iMediSync product uses functional MRIs, which are scans of the brain that show changes in blood flow, to detect abnormalities. This can help doctors diagnose Alzheimer’s disease earlier than ever before by pinpointing what areas of the brain are affected. The system works seamlessly with your existing MRI equipment at any hospital or clinic so that you don’t have to worry about compatibility issues – just plug it in and go!

The iMediSync platform has many benefits over other methods such as PET scans because they provide more information than a simple image might tell us. The platform can detect changes in blood flow, oxygen metabolism, and other important biomarkers. This helps to paint a more complete picture of what is happening in the brain and allows for earlier diagnosis and treatment.

The device Dr. Seung Wan Kang is wearing is the iSyncWave. This one size fits all device successfully conducts an EEG on the individual. The results can be sent to a doctor for review. The headset was also designed with iMediSync’s iSyncBrain/Heart software platform. iSyncBrain “is a cloud AI-guided analytics system for EEG/HRV biosignals.” As for iSyncHeart, this is described as an “HRV (heart rate variability)-based machine learning biomarker report for depression/anxiety detection and stress profiling.”

What does this mean for you?

If you’re at risk for Alzheimer’s or any other form of dementia, iMediSync offers an easy way to detect it early on. You can also use it to maintain your brain health and prevent these diseases from developing in the first place. With its 90%+ accuracy rate, it is one of the most reliable tools available for early detection of these mental disorders. iMediSync offers free tests for those who are interested in learning more about their own brain health and wellness.


If you’d like to learn more about iMediSync, visit the company’s website.

Interview by Scott Ertz of F5 Live: Refreshing Technology.

Sponsored by:
Get $5 to protect your credit card information online with Privacy.
Amazon Prime gives you more than just free shipping. Get free music, TV shows, movies, videogames and more.
The most flexible tools for podcasting. Get a 30 day free trial of storage and statistics.